scispace - formally typeset
P

Peter Arner

Researcher at Karolinska Institutet

Publications -  565
Citations -  56932

Peter Arner is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Adipose tissue & Lipolysis. The author has an hindex of 114, co-authored 553 publications receiving 52710 citations. Previous affiliations of Peter Arner include Karolinska University Hospital & Bristol-Myers Squibb.

Papers
More filters
Journal ArticleDOI

Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.

TL;DR: It is concluded that significant amounts of glycerol are released from skeletal muscle, which suggests that muscle lipolysis provides an important endogenous energy source in humans.
Journal ArticleDOI

Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity

TL;DR: Weight reduction leads to increased efficiency of adipocyte lipolysis with decreased restinglipolysis rate but increased sensitivity to stimulation by catecholamines, which may be attributed to a decreased activity of hormone-sensitive lipase and an increased sensitivity of beta 2-adrenoceptors.
Journal ArticleDOI

Long-Term Prospective and Controlled Studies Demonstrate Adipose Tissue Hypercellularity and Relative Leptin Deficiency in the Postobese State

TL;DR: Adipose tissue hyperplasia (too many small fat cells) and low leptin production resulting in relative hypoleptinemia in the fasting (basal) state are common features of the postobese state in women.
Journal ArticleDOI

Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue.

TL;DR: In conclusion, adipose TNF-alpha may be an important specific and local factor in adipose tissue that influences the ability of insulin to stimulate glucose transport in human fat cells, at least in obese women.
Journal ArticleDOI

Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo

TL;DR: Isoprenaline, but not glucagon or GLP-1, stimulated lipolysis in vitro in isolated human sc adipose tissue and skeletal muscle, and it is concluded that neither glucagon nor GLp-1 affect the lipolytic rate of human sc obesity tissue or skeletal muscle.